WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced that Company Management will be presenting at two upcoming healthcare investor conferences. Canaccord Genuity 2018 Musculoskeletal Conference – New Orleans (March 6, 2018) Adam Gridley, […]